Federal Register Notice for Hepatitis C Testing Among Perinatally Exposed Infants and Children

On November 22, 2022, the Centers for Disease Control and Prevention (CDC) published a Federal Register Notice (FRN) #CDC-2022-0116 to obtain comment on proposed perinatal hepatitis C testing recommendations. The recommendations supplement CDC’s 2020 universal hepatitis C screening recommendations by including testing recommendations for perinatally exposed infants and children. Testing exposed infants with a nucleic acid test (NAT) for HCV ribonucleic acid (RNA) at age 2-6 months is expected to identify more perinatally exposed children and increase opportunities for linkage to care and curative treatment.

The Federal Register Notice, docket number CDC-2022-0116, is open for public comment through January 27, 2023.

Learn More about this Federal Register Notice

CDC hosted a webinar on Tuesday, December 6, 2022, at 3:00pm ET, presenting an overview of the proposed recommendations.

Click here to view the webinar slides


Send questions about the FRN or how to post a comment to: DVHpolicy@cdc.gov